| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT06310382 GH55 for Advanced Cancers With MAPK Mutations: A Study on Safety and Early Results |
overall status: Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07318649 | Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and… | Locally Advanced or Metastatic Solid Tumors | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06306456 | A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets… | Non-Small Cell Lung Cancer With EGFR Mutation | Recruiting |
| NCT06435455 | GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors | Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation | Not Yet Recruiting |
| NCT07446725 | A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients… | Advanced Solid Tumor Cancer | Not Yet Recruiting |
| Phase 1 | |||
| NCT06329206 | A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting |
| NCT06796699 | A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced… | Advanced Solid Tumors With MTAP Gene Deletion | Recruiting |
| NCT07260513 | A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary… | Advanced Solid Tumor Cancer | Active, Not Recruiting |